Clinical Trial Update: Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Glivec (imatinib) monotherapy versus Glivec plus interferon alfa in chronic-phase chronic myeloid leukemia; the study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Glivec (imatinib)
• Interferon-alpha (interferon alpha)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Chronic Myeloid Leukaemia | Phase 4 | Status: COMPLETED